Navigation Links
Their immune cells, fighting your cancer

IMMUNE cells from cancer-resistant people are to be injected into those with cancer to help fight the disease. Zheng Cui at Wake Forest University of Medicine in Winston-Salem, North Carolina, and his colleagues have received permission from the US Food and Drug Administration (FDA) to screen people for their ability to ward off cancer. Immune cells from the best cancer fighters will be given to cancer patients, after being matched for blood type. All of us have some ability to fight cancer, via immune cells called NK cells which can identify and kill tumour cells, although the extent of these cells influence is not known. But Cui has now discovered that a much larger population of immune cells called granulocytes can also kill cancer and that the effectiveness of these cells varies from person to person.

Cui took blood samples from more than 100 people and mixed their granulocytes with cervical cancer cells. While granulocytes from one individual killed around 97 per cent of cancer cells within 24 hours, those from another healthy individual only killed around 2 per cent of cancer cells. Average cancer-killing ability appeared to be lower in adults over the age of 50 and even lower in people with cancer. It also fell when people were stressed, and at certain times of the year. Nobody seems to have any cancer-killing ability during the winter months from November to April, says Cui, who presented preliminary results at the Strategies for Engineered Negligible Senescence meeting in Cambridge, UK, earlier this month.

Initial evidence suggests it may be possible to transfer the ability to fight off cancer between people. Granulocytes are already taken from donors and given to some patients whose immune systems have been depleted by chemotherapy, for example, though not to treat cancer directly. And last year Cui successfully treated a range of different cancers in mice by injecting them with granulocytes from a strain of mice that are completely resistant to cancer (Proceedings of the National Academy of Sciences, DOI: 10.1073/pnas.0602382103).

Cui hopes to begin human trials next summer in the US, when the immune systems of potential granulocyte donors will be at their peak.

The concept of using immune cells from one person to fight cancer in another person is a very hot topic right now, says John Gribben, a cancer immunologist at Cancer Research UKs experimental medicine centre at St Bartholomews Hospital, London.

However, if Cui plans to try this therapy in people, he will have to be very careful, Gribben says. If theyre using live cells there is a theoretical risk of graft-versus-host disease, which can prove fatal. This is a particular problem in patients with depleted immune systems, where transfused cells may proliferate and take over the hosts immune system, eventually destroying cells in the bone marrow. Cui says he is working with the FDA to minimise this risk.


Contact: Claire Bowles
New Scientist

Related medicine news :

1. Starvation in pregnant women can cause heart disease to their children
2. Antibiotics losing their power against acne
3. False beliefs could cost cancer patients their lives
4. People suffering from Alzheimer’s: can they take decisions about their treatment
5. Worms Learn To Choose Their Diet
6. Diabetics and their babies
7. Pregnant smokers could harm their child
8. Healthcare Professionals Might Want To Rethink Their Dress Code
9. Diabetics Can Now Be Able To Control Both Blood Sugar And Their Weight
10. Mother’s Diet Could Prevent Cancer In Their Unborn Children
11. Common Thyroid Problems In Women May Lower Their Risk Of Developing Breast Cancer
Post Your Comments:
(Date:6/26/2016)... Orion, Clarkston, Michigan (PRWEB) , ... June 26, ... ... with respect to fertility once they have been diagnosed with endometriosis. These women ... intercourse but they also require a comprehensive approach that can help for preservation ...
(Date:6/25/2016)... FL (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton Memorial ... Plant City Observer , brings up a new, often overlooked aspect of head lice: the ... closing for fumigation is not a common occurrence, but a necessary one in the event ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar ... M.D from the David Geffen School of Medicine at UCLA. He trained in Internal ... complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... Conventional wisdom ... of success. In terms of the latter, setting the bar too high can result ... more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle Cell Observance ... and the benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, ... Disease. , Sickle Cell Disease (SCD) is a disorder of the red blood cells, ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... Jazz Pharmaceuticals plc (Nasdaq: JAZZ ... Antitrust Improvements Act of 1976, as amended ("HSR"), with ... ("Celator"; Nasdaq: CPXX ) expired effective June ... As previously announced on May 31, 2016, Jazz ... under which Jazz Pharmaceuticals has commenced a tender offer ...
(Date:6/26/2016)... , June 26, 2016 ... value-based care operating models within the health care industry ... greater financial efficiency , Deloitte offers a suite ... key business issues impacting efficient cost optimization: labor resource ... , These services facilitate better outcomes and better economics ...
(Date:6/24/2016)... N.J. , June 24, 2016  Collagen ... the design, development and manufacturing of collagen and ... regeneration announced today that Bill Messer ... and Marketing to further leverage the growing portfolio ... medical devices. Bill joins the Collagen ...
Breaking Medicine Technology: